|
gptkbp:instance_of
|
gptkb:Antihero
|
|
gptkbp:approves
|
gptkb:1993
gptkb:FDA
|
|
gptkbp:atccode
|
R06 AX13
|
|
gptkbp:available_on
|
generic
|
|
gptkbp:brand
|
gptkb:Claritin
gptkb:Alavert
|
|
gptkbp:casnumber
|
79794-75-5
|
|
gptkbp:category
|
B
|
|
gptkbp:chemical_formula
|
C22 H23 Cl N2 O2
|
|
gptkbp:class
|
piperidine derivative
|
|
gptkbp:contraindication
|
hypersensitivity to loratadine
|
|
gptkbp:discovered_by
|
gptkb:Schering-Plough_Corporation
|
|
gptkbp:duration
|
24 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:formulation
|
gptkb:Sugar
tablets
orally disintegrating tablets
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Loratadine
|
|
gptkbp:interacts_with
|
gptkb:beer
CYP2 D6 inhibitors
CYP3 A4 inhibitors
|
|
gptkbp:lifespan
|
8 to 14 hours
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:European_Union
gptkb:India
gptkb:Japan
gptkb:Mexico
gptkb:New_Zealand
gptkb:South_Africa
gptkb:United_States
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:premiered_on
|
1 to 3 hours
|
|
gptkbp:related_products
|
Desloratadine
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
fatigue
headache
drowsiness
dry mouth
|
|
gptkbp:used_for
|
allergic rhinitis
chronic urticaria
|
|
gptkbp:bfsParent
|
gptkb:Claritin-D
|
|
gptkbp:bfsLayer
|
6
|